Block Deal Alert: This Healthcare Company Plunges 7% After 10% Equity Change Hands; Seller Details Here

A substantial portion of the equity in Aster DM Healthcare, one of the hospital chains, saw a change of hands on Wednesday, March 27. A whopping 10.1% equity, equivalent to 5.05 crore shares, valued at Rs 2,070 crore, was traded during the block deal. While the official buyers and sellers remain undisclosed, CNBC-TV18 sources revealed that private equity firm Olympus Capital Asia Investments (OCAI) is likely the seller in the transaction.

According to sources cited by CNBC-TV18, OCAI was likely to divest up to 9.8% of its stake in Aster DM Healthcare via the block deal, marking a significant move in the equity landscape of the healthcare giant. The offer size was estimated at Rs 1,952.8 crore, with an offer price range spanning from Rs 400 to Rs 432 per share, indicating substantial investor interest in the company.

Olympus Capital Asia Investments had previously held an 18.96% stake in Aster DM Healthcare, as reported at the end of the December quarter. This move to divest a substantial portion of its equity signifies a notable shift in the investment strategy of OCAI within the healthcare domain.

The block deal comes amidst robust financial performance showcased by Aster DM Healthcare in the recent quarter. In the December quarter, the company reported a 28.6% surge in net profit, amounting to Rs 179.2 crore compared to Rs 139.4 crore in the corresponding quarter of the previous year. Moreover, the revenue from operations witnessed a commendable uptick of 16.2%, reaching Rs 3,710.6 crore.

At the operational level, Aster DM Healthcare demonstrated robust performance with EBITDA rising by 25.7% to Rs 564 crore in the third quarter of the fiscal year, compared to Rs 448.6 crore in the corresponding period of the previous fiscal. Notably, the EBITDA margin stood at 15.2% in the reporting quarter, indicating enhanced operational efficiency and profitability.

Despite the strong financial performance, shares of Aster DM witnessed a decline of over 7% during trading hours, settling at Rs 406 per share as of 12:15 pm on the National Stock Exchange (NSE). However, it's imperative to note that the stock has surged by nearly 85% over the past year, reflecting investor confidence in the company's long-term growth prospects.

The block deal not only signifies a significant reshuffle in the shareholding pattern of Aster DM Healthcare but also underscores the dynamic nature of the Indian healthcare sector. As stakeholders closely monitor the developments, the transaction paves the way for potential strategic realignments within the company and offers valuable insights into the evolving investment landscape of the healthcare industry.